Cancer research
Research has unveiled a significant breakthrough in the fight against pleural mesothelioma, a devastating form of cancer affecting the lining surrounding the lungs. By analyzing data from The Cancer Genome Atlas (TCGA) and conducting experimental validations, a team of scientists has developed a novel prognostic gene signature that can accurately
Cancer research
Researchers from the University of Toronto have published a new study on the impact of CRISPR gene editing on cancer research. According to the study, CRISPR tools are transforming the field of oncology by enabling the creation of cancer models, studying tumor evolution, and identifying genes involved in cancer growth
Cancer
Researchers at Saveetha Medical College and Hospital in Tamil Nadu, India, have made significant progress in the development of surfactant-based drug delivery systems for cancer gene therapy. These systems have the potential to revolutionize oncology treatments by improving drug efficacy, reducing systemic toxicity, and enabling precision medicine. Key Takeaways: * Surfactant-based
Cancer
Research conducted by scientists at the Fred Hutchinson Cancer Research Center has led to significant advancements in understanding the biology of gene regulation in eukaryotic genomes. According to the study, the biochemical principles of factor binding to DNA have been well-established through in vitro studies, and the structural interactions between
Cancer
Researchers from Wayne State University have made significant progress in developing cancer gene therapy, focusing on KRAS mutations that are common in various cancers and associated with aggressive disease and poor clinical outcomes. By understanding the binding process of KRAS to GDP/GTP, scientists have been able to design direct
Cancer
Research conducted at Islamic Azad University in Ardebil, Iran, has made significant strides in cancer gene therapy by successfully developing polyspermine-peg-glucose/DNA nanoparticles for targeted gene delivery to MCF-7 cells. This innovative approach utilizes cationic polymers to electrostatically interact with negatively charged DNA, enabling efficient and targeted delivery of genetic
Cancer research
Investigators at Lucile Packard Children's Hospital Stanford have published a review exploring the inhibitory effects of natural compounds on multiple myeloma cells. The research highlights the potential of these compounds to target cancer cells, but also emphasizes the need for improved delivery methods to enhance their therapeutic efficacy.
Cancer
Researchers from BioMarin Pharmaceutical Inc. have presented a molecular characterization of adeno-associated virus (AAV) integration profiles in human biopsy samples from valoctocogene roxaparvovec clinical trials and nonhuman primates (NHPs) treated with the same gene therapy. The study aimed to assess the integration profiles of the AAV vector, which is used
Cancer research
Research conducted at the Memorial Sloan-Kettering Cancer Center in New York City has shed light on the relationship between mitochondrial genome variants and glioma grade, as well as patient survival in glioblastoma (GBM) patients. The study, which analyzed germline mtDNA sequencing for 388 patients with incident glioma, identified associations between
Cancer
Researchers from the Chinese University of Hong Kong have made a breakthrough discovery in understanding the role of the DMD gene in gastric cancer. According to a recent study published in Cancer Cell International, the DMD gene is significantly downregulated in gastric cancer cells and tissues, leading to altered calcium
Cancer
Gene fusions play a pivotal role in cancer development by activating kinases or inactivating tumor suppressor genes, leading to altered signal transduction and gene expression regulation. However, their impact on treatment responses remains poorly understood. The lack of a unified platform integrating gene fusion data across cancer types, linking them
Cancer
Advances in messenger RNA (mRNA) vaccines have revolutionized immunization by encoding specific proteins that elicit targeted immune responses. However, the inherent instability of mRNA and its vulnerability to enzymatic degradation necessitate the development of sophisticated delivery systems. Researchers at the Isfahan University of Medical Sciences have explored the latest advancements
